H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 429,954. Minnesota Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Minneapolis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Minneapolis storefront.
Growth Factor Therapy for Tissue Repair in Minneapolis, MN for clinics & physicians. Growth factor therapy… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Minneapolis is J6 (National Government Services (NGS)) and that adult diabetes here is 7.4% (PLACES 2023), it is selling units, not a program. That is the growth factor therapy conversation we actually have.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)Three grains, kept separate on purpose. City: Census 429,954 and CDC PLACES crude rates. State: Minnesota Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Adult arthritis here is 15.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Minneapolis.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 28.6%; arthritis is 15.2%. That is place-level BRFSS modeling, not a clinic census and not a Minneapolis trial.
Minnesota is in CMS MAC J6, administered by National Government Services (NGS). CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J6 reviewers and surveyors expect — not a brochure.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Minneapolis medical practice or that we hold a local facility license.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Minneapolis, MN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Minneapolis is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Minneapolis — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Minnesota Part B wound biologics follow this contractor (siblings: IL, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Minneapolis. Useful for joint-program math; still needs a diagnosis and privileging.
No Minneapolis storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.